Neuropsychologic side‐effects of tacrolimus in pediatric renal transplantation
Authors:
- 28 April 2003
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 17 (2) , 130-134
Abstract
Calcineurin inhibition with tacrolimus has been used after renal transplantation (RTPL) as rescue therapy for insufficient immunological control or if cyclosporin A (CSA) toxicity occurred. Neurologic side‐effects occur but are rare in children, usually presenting as tremor; however, serious complications, e.g. the posterior leukoencephalopathy syndrome are also documented. Twenty children (10 girls) were switched to tacrolimus: 11 (55%) for immunological reasons (n = 9: steroid‐resistant rejection; n = 2: recurrent rejections) and nine for CSA side‐effects. Tacrolimus was started at a median of 8 wk (range 10 d to 8.7 yr) after RTPL and was continued for a median of 2.5 yr (range 5 wk to 4.6 yr). Renal function significantly improved over a period of 12 months following conversion to tacrolimus (glomerular filtration rate 56 ± 19 vs. 66 ± 16 mL/min/1.73 m2; p < 0.03; n = 13). Fifteen of 20 (75%) patients tolerated tacrolimus well.The most frequent side‐effects were neuropsychological and behavioral symptoms in three children, ranging from anorexia nervosa‐like symptoms with weight loss, amenorrhea, depression and school problems to severe insomnia and to aggressive and anxious behavior in one child. Only the latter child was exposed to toxic tacrolimus blood levels. All side‐effects were fully reversible after discontinuation of tacrolimus. In conclusion, tacrolimus had a beneficial effect on renal function and was well tolerated in the majority of pediatric patients. However, neuropsychologic and behavioral side‐effects are important and maybe underrecognized in children.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre studyThe Lancet, 2002
- SEVERE AXONAL POLYNEUROPATHY AFTER A FK506 OVERDOSAGE IN A LUNG TRANSPLANT RECIPIENTTransplantation, 2001
- Indications, results, and complications of tacrolimus conversion in pediatric renal transplantationPediatric Transplantation, 2001
- Indications, results, and complications of tacrolimus conversion in pediatric renal transplantationPediatric Transplantation, 2001
- Tacrolimus: The good, the bad, and the uglyPediatric Transplantation, 2001
- Neurotoxicity of calcineurin inhibitors: impact and clinical managementTransplant International, 2000
- Neurotoxicity of calcineurin inhibitors: impact and clinical managementTransplant International, 2000
- TacrolimusDrugs, 2000
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantationTransplant International, 1994